| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.81B | 107.79B | 101.26B | 77.98B | 71.19B | 66.18B |
| Gross Profit | 25.57B | 25.41B | 22.87B | 17.42B | 15.76B | 13.94B |
| EBITDA | 19.65B | 19.47B | 17.75B | 13.35B | 12.16B | 10.51B |
| Net Income | 11.89B | 11.79B | 10.26B | 10.22B | 7.82B | 6.37B |
Balance Sheet | ||||||
| Total Assets | 83.43B | 90.48B | 86.41B | 68.16B | 63.27B | 59.46B |
| Cash, Cash Equivalents and Short-Term Investments | 28.62B | 30.36B | 29.42B | 38.37B | 31.82B | 30.09B |
| Total Debt | 1.51B | 1.93B | 3.38B | 200.95M | 281.12M | 225.96M |
| Total Liabilities | 19.70B | 22.23B | 22.37B | 12.70B | 11.43B | 10.28B |
| Stockholders Equity | 62.84B | 67.42B | 62.37B | 54.71B | 51.19B | 48.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.71B | 11.90B | 9.95B | 6.97B | 7.91B |
| Operating Cash Flow | 0.00 | 12.30B | 12.19B | 10.07B | 7.24B | 8.16B |
| Investing Cash Flow | 0.00 | 904.00M | -17.85B | 6.02B | -377.12M | -658.56M |
| Financing Cash Flow | 0.00 | -10.27B | -5.77B | -7.57B | -6.15B | -3.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥48.09B | 12.84 | 8.02% | 2.73% | 8.26% | 9.09% | |
77 Outperform | ¥201.37B | 18.05 | ― | 2.49% | 9.10% | 14.67% | |
77 Outperform | ¥28.77B | 12.67 | ― | 2.93% | 11.53% | 23.23% | |
77 Outperform | ¥74.26B | 21.08 | 31.71% | 1.68% | 16.12% | 46.57% | |
72 Outperform | ¥48.96B | 23.84 | ― | 1.50% | 13.48% | 35.63% | |
68 Neutral | ¥169.04B | 35.85 | 24.24% | ― | 17.35% | 74.71% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |